蛋白质亚单位
动力学
化学
肽
抗原
结合
生物物理学
佐剂
接种疫苗
微球
免疫系统
T细胞
效价
dna疫苗
受体-配体动力学
分子生物学
细胞生物学
细胞
限制
寡核苷酸
免疫学
自愈水凝胶
分泌物
免疫
生物化学
控制释放
B细胞
抗体
作者
Fengyun Shen,Lingling Yan,He Sun,Junjie Wu,Qi Wang,Yanfei Qu,Xiaolei Zuo,Lele Sun
出处
期刊:Small
[Wiley]
日期:2026-11-17
卷期号:: e76776-
摘要
Conventional vaccine sustained release strategies exhibit monophasic antigen kinetics that fail to align with the temporal order of T and B cell activation, limiting single-dose efficacy. Using a protein-carrier peptide vaccine model, we designed an alginate-DNA core-shell hydrogel microsphere that programmed differential antigen release kinetics through orthogonal loading mechanisms. Physical encapsulation enabled carrier protein release within 3 days to prime T cells, while DNA cross-linking sustained epitope-carrier protein conjugate release over 11 days to drive B cell responses, achieving a release interval exceeding 8 days that orchestrates sequential T and B cell activation. In a single immunization, this strategy induces significantly higher epitope-specific IgG titers compared to formulations with either co-rapid or co-sustained release. A SARS-CoV-2 peptide vaccine based on our strategy elicits substantially stronger humoral immunity than traditional aluminum-adjuvanted vaccines. This work establishes orthogonal loading-mediated kinetic programming as a versatile platform for next-generation single-injection subunit vaccines.
科研通智能强力驱动
Strongly Powered by AbleSci AI